These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22088983)

  • 1. The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degeneration.
    Davis SJ; Lyzogubov VV; Tytarenko RG; Safar AN; Bora NS; Bora PS
    Retina; 2012 Jun; 32(6):1171-80. PubMed ID: 22088983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine increases size and severity of experimental choroidal neovascularization.
    Suñer IJ; Espinosa-Heidmann DG; Marin-Castano ME; Hernandez EP; Pereira-Simon S; Cousins SW
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):311-7. PubMed ID: 14691189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model.
    Pan CK; Durairaj C; Kompella UB; Agwu O; Oliver SC; Quiroz-Mercado H; Mandava N; Olson JL
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):219-24. PubMed ID: 21574814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation.
    Tatar O; Shinoda K; Kaiserling E; Claes C; Eckardt C; Eckert T; Pertile G; Boeyden V; Scharioth GB; Yoeruek E; Szurman P; Bartz-Schmidt KU; ; Grisanti S
    Br J Ophthalmol; 2009 Feb; 93(2):159-65. PubMed ID: 18838410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization.
    Kiuchi K; Matsuoka M; Wu JC; Lima e Silva R; Kengatharan M; Verghese M; Ueno S; Yokoi K; Khu NH; Cooke JP; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1705-11. PubMed ID: 18385094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal tumor necrosis factor-alpha inhibitors for neovascular age-related macular degeneration suboptimally responsive to antivascular endothelial growth factor agents: a pilot study from the Pan American Collaborative Retina Study Group.
    Wu L; Arevalo JF; Hernandez-Bogantes E; Regatieri CV; Roca JA; Farah ME
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):366-71. PubMed ID: 23215543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
    Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
    Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
    Gross N; Ranjbar M; Evers C; Hua J; Martin G; Schulze B; Michaelis U; Hansen LL; Agostini HT
    Mol Vis; 2013; 19():54-61. PubMed ID: 23335851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
    Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
    Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability.
    Nagai N; Ju M; Izumi-Nagai K; Robbie SJ; Bainbridge JW; Gale DC; Pierre E; Krauss AH; Adamson P; Shima DT; Ng YS
    Am J Pathol; 2015 Sep; 185(9):2534-49. PubMed ID: 26188133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy.
    de Oliveira Dias JR; Rodrigues EB; Maia M; Magalhães O; Penha FM; Farah ME
    Br J Ophthalmol; 2011 Dec; 95(12):1631-7. PubMed ID: 21546514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.
    Rush RB; Rush SW; Aragon AV; Ysasaga JE
    Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.
    Chan WM; Lai TY; Chan KP; Li H; Liu DT; Lam DS; Pang CP
    Retina; 2008 Oct; 28(9):1308-13. PubMed ID: 18728623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
    Song JH; Moon KY; Lee SC; Kim SS
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of VEGF inhibition on retinal morphology, neovascular network size, and visual acuity in patients with vascularized pigment epithelium detachment because of occult choroidal neovascularization.
    Veritti D; Macor S; Menchini F; Lanzetta P
    Retina; 2013 May; 33(5):982-9. PubMed ID: 23296046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activation.
    Wang H; Han X; Wittchen ES; Hartnett ME
    Mol Vis; 2016; 22():116-28. PubMed ID: 26900328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone.
    Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.